Cannabis · New York
New York Cannabis Accounting for Licensed Operators.
New York is the only state where licensed operators get two separate layers of 280E relief, one at state level and one in New York City. Most operators have claimed neither properly. We handle the decoupling, the three-part excise structure, and OCM reporting.
Talk to a Cannabis CPA The Two Layers ExplainedNew York cannabis accounting turns on a fact no other state offers: two separate layers of 280E decoupling. At state level, the 2022-2023 budget bill signed April 9, 2022 decoupled New York from federal Section 280E for licensed operators, effective for tax years beginning on or after January 1, 2023. The city then decoupled separately under S7508, signed November 17, 2023, covering the Unincorporated Business Tax, General Corporation Tax, and Business Corporation Tax, retroactive to tax years beginning January 1, 2022.
The excise structure changed on June 1, 2024, when the THC potency tax was repealed. Adult-use now carries a 9 percent wholesale excise on distributor transfers plus a 13 percent retail excise at point of sale, made up of 9 percent state and 4 percent local. Medical cannabis is exempt from the adult-use excise and instead pays a 3.15 percent gross receipts excise, down from 7 percent. Vertically integrated Registered Organizations and microbusinesses apply the 9 percent wholesale rate to 75 percent of the retail price.
Federally, the April 2026 order moved state-licensed medical cannabis to Schedule III, lifting 280E for qualifying medical operations. Adult-use remains Schedule I. The Office of Cannabis Management regulates both programs under the Cannabis Control Board. GreenGrowth CPAs has worked in cannabis accounting since 2016 and is an AICPA member firm and PCAOB registered.
Last reviewed and updated: September 2026
Operating in NYC and unsure whether you claimed both layers?Most operators we review have claimed one or neither, and the city layer runs retroactive to 2022. Get a read on your position →
The New York Advantage
Two Layers of 280E Relief. Most Operators Claim One.
Federal law still disallows ordinary business deductions for adult-use cannabis under IRC Section 280E. New York does not follow that treatment, and neither does New York City. That produces a position available nowhere else in the country, and capturing it depends entirely on how the returns were prepared.
Layer one: New York State
The 2022-2023 state budget bill, signed April 9, 2022, decoupled New York from federal Section 280E for licensed cannabis operators. It took effect for tax years beginning on or after January 1, 2023.
So state returns from tax year 2023 onward should already reflect ordinary business expense deductions. Returns prepared on federal 280E logic did not, and that is a correctable position.
Layer two: New York City
S7508, signed November 17, 2023, decoupled the city's Unincorporated Business Tax, General Corporation Tax, and Business Corporation Tax from 280E. It applies retroactively to tax years beginning January 1, 2022.
That retroactivity is the part most operators miss. A city return filed for 2022 under federal logic may carry a material amended return opportunity.
Federal, for medical only
The April 2026 order moved state-licensed medical cannabis to Schedule III, lifting 280E federally for qualifying medical operations. Adult-use stays on Schedule I.
A qualifying NYC medical operator therefore has deductibility on all three returns at once. A dual-licence operator has it on some activity and not other activity, which makes the expense split an accounting problem with a direct tax consequence.
Treasury and the IRS have said further guidance on the rescheduling is forthcoming. Positions taken now should be documented on the basis they were taken, so they can be revisited when that guidance arrives.
Filed a NYC return for 2022 or later under federal 280E logic?The city decoupling reaches back to 2022, so that return may be worth revisiting. Have us review it →
Where Federal Rescheduling Stands
The Broader Hearing Is Done. The Decision Is Not.
New York adult-use operators have a direct interest in whether cannabis is rescheduled more broadly, since that would end 280E federally for adult-use as well. Here is the actual state of the proceeding, which is frequently reported inaccurately.
| Stage | What Happened |
|---|---|
| April 2026 order | FDA-approved cannabis drug products and cannabis under a state medical licence moved from Schedule I to Schedule III. Adult-use was not included. |
| Expedited hearing | The DEA administrative hearing on broader rescheduling ran from June 29 to July 15, 2026. |
| Post-hearing briefing | Participants filed closing briefs. The DEA's own final brief argued that cannabis should move to Schedule III. |
| Where it sits now | The administrative law judge has not issued a recommendation. No decision has been made and no timeline has been set. |
| What applies today | Adult-use cannabis in New York remains Schedule I and fully subject to IRC 280E federally. State and city decoupling still apply. |
Planning for the possibility of broader rescheduling is reasonable. Building a budget that assumes it is not. Any resulting rule would also face likely legal challenge, so the timeline stays open. Confirm the current position before relying on it for a filing.
What We Bring
Six Things New York Operators Ask Us For.
A lookback across state returns from 2023 and city returns from 2022, confirming whether both layers were applied and whether amended returns are worth filing.
Expense segregation for dual-licence operators, where medical activity sits outside 280E federally and adult-use activity sits inside it.
The 9 percent wholesale, the 13 percent retail, and the 3.15 percent medical gross receipts excise, filed through the Department of Taxation and Finance Web File portal.
Wholesale excise calculation for vertically integrated Registered Organizations and microbusinesses with no separate wholesale transfer to price against.
Cost of goods sold methodology built to survive examination, which remains the largest lever on the federal bill for adult-use activity.
Financial reporting aligned to Office of Cannabis Management expectations, licence renewals, and Cannabis Control Board oversight.
GreenGrowth CPAs is an AICPA member firm and PCAOB registered, serving cannabis clients nationwide from eight offices.
Which of these six is costing you the most right now?Most operators know. A short call turns that instinct into a number. Talk it through →
Holding both a medical and an adult-use licence?
Those now sit under two different federal tax regimes. Every shared cost has to be split, and there is no IRS default method to fall back on.
The Tax Stack
What New York Operators Actually Pay.
The structure changed materially on June 1, 2024, when the THC potency tax was repealed. That single change cut the effective combined burden from roughly 38 percent to around 22 percent, which is why pricing models built before it are now wrong.
| Charge | Rate | Applies To |
|---|---|---|
| Wholesale excise | 9% | Distributor transfers of adult-use cannabis to retailers. Vertically integrated operators apply it to 75 percent of retail price. |
| Retail excise | 13% | Adult-use retail sales at point of sale, made up of 9 percent state and 4 percent local. Adult-use is not subject to regular sales tax. |
| Medical excise | 3.15% | Gross receipts of medical cannabis sold by Registered Organizations, reduced from 7 percent. Embedded in pricing rather than added as a line. |
| New York State income tax | Decoupled from 280E | Ordinary business expenses deductible for licensed operators from tax year 2023. |
| New York City UBT, GCT, BCT | Decoupled from 280E | Ordinary business expenses deductible, retroactive to tax year 2022. |
| Federal IRC 280E | Effective rate varies | Still disallows ordinary deductions for adult-use. Lifted for qualifying state-licensed medical operations since April 2026. |
Excise filings run through the New York State Department of Taxation and Finance Web File portal. Confirm current rates with the Department and the Office of Cannabis Management before filing.
Still pricing off the old potency tax model?The June 2024 repeal changed the arithmetic on every SKU. Rebuild the model →
Who We Work With
Every New York Licence Type.
The accounting problem changes with the licence. A distributor carries the wholesale excise. Retailers instead carry the 13 percent and the point-of-sale reconciliation. Registered Organizations carry both, plus the 75 percent basis rule and a medical and adult-use split.
Not open yet? Our guide to the financial steps to open a cannabis dispensary in New York covers capital documentation, build-out budgeting, and the accounting to set up before day one.
Vertically integrated?The 75 percent basis rule and the medical split are where most New York accounting errors originate. Talk to a specialist →
Why New York Is Different
More Relief Available, More Ways to Miss It.
New York gives operators more tax relief than any other state. It also asks more of the accounting, because capturing the relief depends on records most operators were not keeping when the rules changed.
Three sets of books, effectively
Your federal position applies 280E to adult-use. The state position does not. Neither does the city position, which reaches back further than the state one.
Reconciling three treatments of the same expenses is a chart of accounts problem before it is a tax problem. Reconstructing it after year end is slow and tends to leave money behind.
Dual licences split the federal picture
Since April 2026, medical activity sits outside 280E federally while adult-use sits inside it. Operators holding both run two regimes at once.
Every shared cost, from rent to security to management salaries, has to be allocated between them. The IRS has published no default method, so the methodology you document is the methodology you defend.
The excise base is not obvious
A vertically integrated operator has no wholesale transfer to price against, so the 9 percent applies to 75 percent of retail instead.
Get that base wrong and the error repeats on every transaction until someone catches it. It is one of the more common New York findings we see on review.
Can your books produce a federal, a state, and a city position from one set of records?If that takes a rebuild each year, the structure is the problem. Book a review →
Scope of Services
What We Deliver for New York Operators.
Three service lines, each linked to the practice that runs it.
Cannabis Tax and Compliance
IRC 280E strategy and COGS allocation, New York State and New York City decoupling review, amended returns where the position supports one, wholesale and retail excise filings, and medical versus adult-use expense segregation.
Tax planning and compliance →Cannabis Accounting
A chart of accounts that carries federal, state, and city positions from one set of records, monthly close, seed-to-sale reconciliation, inventory and cost accounting, and OCM-ready reporting.
Accounting and financial services →Outsourced CFO
Pricing and margin modelling under the post-2024 excise structure, cash flow forecasting, capital planning, board and investor reporting, and support through expansion or a sale process.
Outsourced CFO services →Amended returns worth filing?
The city decoupling reaches back to 2022 and the state to 2023. Both have limits, and the window on the earliest years is the one that closes first.
Common Questions
New York Cannabis Accounting FAQs.
New York cannabis taxes
What taxes do cannabis businesses pay in New York?
Adult-use cannabis carries a 9 percent wholesale excise, paid by distributors on transfers to retailers, plus a 13 percent retail excise at point of sale made up of 9 percent state and 4 percent local. Adult-use is not subject to the regular sales tax. Medical cannabis is exempt from the adult-use excise and instead pays a 3.15 percent gross receipts excise, reduced from 7 percent. Registered Organizations and microbusinesses selling direct to consumers apply the 9 percent wholesale rate to 75 percent of the retail price. All cannabis excise filings go through the New York State Department of Taxation and Finance Web File portal.
What changed in New York cannabis taxes in June 2024?
New York repealed the THC potency-based tax effective June 1, 2024. That system charged by milligram of THC, at different rates for flower, concentrates, and edibles, and it was complex to administer and expensive to comply with. It was replaced with a 9 percent wholesale excise and a 13 percent retail excise. The change was estimated to cut the effective combined cannabis tax burden from roughly 38 percent to around 22 percent, with the aim of making the legal market more competitive against the unlicensed one. The medical excise dropped from 7 percent to 3.15 percent at the same time.
What is the 75 percent basis rule?
Registered Organizations and microbusinesses are vertically integrated, handling cultivation, processing, and retail under one licence. Because there is no separate wholesale transfer to price against, the 9 percent wholesale excise applies to 75 percent of the final retail price rather than an actual wholesale price. The 13 percent retail excise then applies on top, calculated on the full retail price. Getting the base wrong repeats the error on every transaction, which is one of the more common findings when we review a New York operator's filings.
280E and decoupling
Does New York decouple from federal 280E?
Yes, and uniquely it happens twice. New York State decoupled for licensed cannabis operators effective for tax years beginning on or after January 1, 2023, under the 2022-2023 budget bill signed April 9, 2022. New York City decoupled its Unincorporated Business Tax, General Corporation Tax, and Business Corporation Tax separately under S7508, signed November 17, 2023, retroactive to tax years beginning January 1, 2022. A New York City operator can therefore deduct ordinary business expenses at both state and city level even where federal law disallows them for adult-use activity. No other state offers two layers.
Can we amend prior returns to claim the decoupling?
Often, and the city layer is where the larger opportunity usually sits because it reaches back to tax year 2022. Returns prepared on federal 280E logic will have disallowed expenses that New York and New York City both allow. Whether amending makes sense depends on the amounts involved, the years still open under the statute of limitations, and how well the underlying records support the position. We start by quantifying what is recoverable before recommending anything, since an amended return that cannot be supported is worse than no amended return.
How does the April 2026 federal rescheduling affect New York operators?
State-licensed medical cannabis moved from Schedule I to Schedule III in April 2026, lifting IRC 280E federally for qualifying medical operations. Adult-use cannabis remains Schedule I and fully subject to 280E. For a New York City medical operator, that produces deductibility on federal, state, and city returns at once. For an operator holding both medical and adult-use licences, it means running two federal tax regimes simultaneously, with every shared cost allocated between them. Treasury and the IRS have said further guidance is forthcoming, so positions should be documented on the basis they were taken.
Working with GreenGrowth CPAs
What is the status of broader cannabis rescheduling?
The DEA held an expedited administrative hearing on broader rescheduling from June 29 to July 15, 2026. Participants filed post-hearing briefs, and the DEA's own final brief argued that cannabis should move to Schedule III. The administrative law judge has not issued a recommendation, no decision has been made, and no timeline has been set. Any resulting rule would also face likely legal challenge. Planning for the possibility is sensible; budgeting on the assumption is not. Adult-use cannabis in New York remains Schedule I today.
Do we need a cannabis-specialised CPA in New York?
For a licensed operator, yes. New York layers three separate excise charges, a basis rule that applies only to vertically integrated operators, and two levels of 280E decoupling with different effective dates. A generalist CPA will rarely have met any of them, and typically will not build cost of goods sold allocation around 280E at all. The usual outcome is one of two things: overpaying federal tax through missed COGS opportunities, or leaving the state and city decoupling partly unclaimed.
How do we move from our current accountant?
We start with an onboarding review covering prior federal, state, and city returns, your excise filings, and how your chart of accounts handles the three positions. That surfaces both risk and missed opportunity before you commit to anything. Next we request records from your existing accountant and agree a handover date. Most transitions happen between filing periods, though we regularly pick up mid-year where a return is outstanding or an amended filing window is closing.
Explore More From GreenGrowth CPAs.
New York cannabis accounting sits within our cannabis CPA practice, alongside Massachusetts, Maine, Connecticut, New Jersey, and Maryland. Service lines include tax planning and compliance, tax controversy, accounting and financial services, and outsourced CFO. About GreenGrowth CPAs.
Talk About Your New York Operation.
Send us your licence types, whether you operate inside New York City, and which years have been filed. We will come back with what the decoupling is worth to you and where the exposure sits.
Talk to a Cannabis CPA